Desobit M Tablet
Manufacturer
Brinton Pharmaceuticals Pvt Ltd
Salt Composition
Desloratadine (5mg) + Montelukast (10mg)
Key Information
Short Description
Desobit M Tablet is a combination medicine used to treat allergy symptoms such as runny nose, stuffy nose, sneezing, watery eyes, and congestion or stuffiness.
Dosage Form
Tablet
Introduction
Desobit M Tablet is a combination medicine used in the treatment of allergy symptoms such as runny nose, stuffy nose, sneezing, watery eyes, and congestion or stuffiness. It is a combination of two medicines: Desloratadine and Montelukast, which treats sneezing and runny nose caused due to allergies.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Desobit M Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety Information
Side Effects
No common side effects listed
Alcohol Warning
Caution is advised when consuming alcohol with Desobit M Tablet. Please consult your doctor.
Breastfeeding Warning
Desobit M Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Desobit M Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Desobit M Tablet is a combination of two medicines: Desloratadine and Montelukast, which treats sneezing and runny nose caused due to allergies. Desloratadine is an antiallergic which blocks the action of a chemical messenger (histamine) responsible for runny nose, watery eyes, and sneezing. Montelukast is a leukotriene antagonist. It works by blocking the action of another chemical messenger (leukotriene). This reduces inflammation (swelling) in the airways and nose and improves symptoms.
Quick Tips
You have been prescribed Desobit M Tablet to help relieve symptoms of allergy such as runny nose, sneezing, watery eyes, and cough. Be cautious while driving or doing anything that requires concentration as Desobit M Tablet can cause dizziness and sleepiness. Do not drink alcohol while taking Desobit M Tablet as it may cause increased sleepiness. Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake, and sugarless candy may help. Stop taking Desobit M Tablet at least three days before taking an allergy test as it can affect the test results.
Related Medicines
Mondeslor Tablet
Dazit M Tablet
Gredes M 5mg/10mg Tablet
Allerde M Tablet
Mont Loreva 5mg/10mg Tablet
Destano-M Tablet
Denol M 5mg/10mg Tablet
Monti-DL Tablet
Desolate M 5mg/10mg Tablet
Malevo M 5mg/10mg Tablet
Frequently asked questions
Should Desobit M Tablets be stopped when allergy symptoms subside?
Desobit M Tablets should not be stopped without consulting a doctor. If there are concerns regarding the medication, contact a healthcare professional for guidance.
Does Desobit M Tablet cause dry mouth?
Yes, Desobit M Tablets can contribute to dry mouth. It is recommended to stay well-hydrated by drinking plenty of fluids throughout the day and having water readily available at night.
What should be avoided when taking Desobit M Tablets?
It is advised to avoid consuming fruit juices, including apple, orange, or grapefruit, along with this medication as they may reduce the effectiveness of Desobit M. Additionally, alcohol consumption should be minimized while using this medication, as it can increase drowsiness and sleepiness.
Is higher dose of Desobit M Tablet more effective?
Taking a higher dose of Desobit M Tablets will not enhance its effectiveness. Instead, it may lead to increased side effects. If you experience worsening symptoms, consult your doctor for re-evaluation.
Can I use Desobit M Tablets while breastfeeding?
Desobit M Tablets are not recommended during breastfeeding. It is essential to inform your doctor if you are currently breastfeeding so they can provide guidance on alternative options.
